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Registries of Congenital Anomalies:
EUIROCAT
by Michel F. Lechat' and Helen Dolk1
Congenital anomalies are one ofthe potential adverse effects of the environment on reproductive health.
Registries of congenital anomalies are useful to detect abnormal frequencies, clusters, and trends. Such
registries should meet a number ofconditions, including an appropriate population denominator, an efficient
system for collecting information, standardized diagnostic procedures, postmortem examinations of still-
births, and linkage ofrecords. The EUROCAT (European Registration ofCongenital Anomalies and Twins)
program is a Concerted Action ofthe Commission ofthe European Communities initiated in 1979. One ofits
objectives is the surveillance ofcongenital anomalies as related to environmental hazards. This surveillance
system covers at present 350,000 births per year in 15 countries. A number of problems encountered in the
development of EUROCAT and in the course of ongoing activities are reviewed: populations coverage,
classification of malformations, coding, definition and coverage of late fetal death, registration of induced
abortion, validation of diagnostic information, registration of late diagnosed-cases, and maintenance of
motivation indatacollection. The issue ofconfidentiality andthe need forstrictsafeguards forthe protection
ofindividual privacy are emphasized.
Introduction
The diversity ofreproductive health outcomes must be
met by a diversity ofinformation systems that respond in
their design to the particular problems of definition and
diagnosis ofeach outcome and its social and medical con-
text. Here we concentrate on congenital anomalies.
There are many environmental factors that at one time
or another have been suspected of playing a role in the
causation of congenital anomalies. Chemical pollutants,
dietaryimbalance, ionizingradiation, pharmaceutical sub-
stances, and infections are, among others, known or sus-
pected agents.
These same teratogenic agents may lead to other
adverse pregnancy outcomes also. Congenital anomalies
are monitored notonlyfortheirintrinsicimportance as an
important cause ofmorbidity and mortality, but for their
use as an indicator of other potential adverse outcomes
which may be less amenable to surveillance. Spontaneous
abortions, for example, are not systematically reported,
and later behavioral outcomes are as yet ill defined and
unreliably recorded.
As potential indicators to monitor the effects of the
environment on reproductive health, congenital anomalies
1Department ofEpidemiology and Preventive Medicine, Catholic Uni-
versity of Louvain, 1200 Brussels, Belgium.
Thismanuscript waspresented atthe Conference on the Impact ofthe
Environment on Reproductive Health that was held 30 September-A
October 1991 in Copenhagen, Denmark.
have the relative advantage ofoften, though certainly not
always, manifesting themselves within a few months of
exposure.
Surveillance of the occurrence of malformed fetuses
andchildrenshouldindicatequicklyachangeinfrequency
and allowepidemiological investigation ofthe origin ofthe
increase. Practically, the efficacy of surveillance may be
limited by the quality of the information system and the
lackofclearhypothesesunderpinningstatisticalanalyses.
Registries ma-y be defined as information systems that
exhaustively and continuously collect and record all the
cases ofa given disease in awell defined population. They
address problems that cannot be appropriately studied by
adhocsurveysandforwhichselectivehospital statistics or
mortality data provide a biased picture.
Registries are useful for monitoring temporal or geo-
graphical differences in the frequencies of diseases, for
specific epidemiological studies to identify etiological fac-
tors, to delineate vulnerable population groups, to study
survival, ortoplanandevaluatehealthcare.Thetwoareas
of environmental monitoring and health service planning
and evaluation are complementary, and the information
collected should be appropriate to both.
Aregistryforcongenital anomalies should meetthe fol-
lowingcriteria: a) abirthnotification systemmustprovide
apopulation denominator and some minimal demographic
information (maternal age, geographic distribution ofres-
idence); b) quality of the diagnostic information collected
shouldbehighandshouldbebasedonstandarddefinitions
andterminology; c)multiple sourcesofinformation shouldLECHATAND DOLK
be used; d) linkage between different sources ofinforma-
tion concerning the same child must be possible; e) case
identification should be as minimally biased as possible by
survival characteristics (stillbirths, neonatal deaths,
induced abortions following prenatal diagnosis, and sur-
viving livebirths should be equally reported) or by age at
diagnosis,J) the analysis, validation, and follow-up of the
data collected should be foreseen, either as part of the
registry activities orby a closely collaborating institution,
with the necessary facilities for processing statistics and
with an interdisciplinary approach including clinicians,
dysmorphologists, epidemiologists, and toxicologists/
teratologists.
Atthe present, a number ofregistries forcongenital ano-
malies exist in Europe. Registration maytake the form ofa
national system ofspecific notification ofcongenital anomal-
ies (England and Wales, Finland, Sweden, Czechoslovakia,
and Hungary), ofcentralized birth notifications (Norway,
Belgium, and Sweden), or of neonatal discharge records
(Scotland), or specialized (often regional) registries using
multiple sourcesofinformation. EUROCATis anetworkof
specialized regional registries in Europe with central
coordination. ManyofthelargerEuropeanregistrieshave
been collaborating with other registries worldwide under
the umbrella ofthe International Clearinghouse for Birth
Defect Monitoring Systems. This paper will be restricted
to our experience in EUROCAT.
EUROCAT is a concerted action ofthe Commission of
the European Communities. The EUROCAT system of
surveillance ofcongenital anomalies began in 1979 with a
number of objectives: to provide baseline epidemiologic
information on congenital anomalies in Europe, to monitor
trends in frequency, and to assure the continuous evalua-
tion of the population impact of prenatal diagnosis and
termination of pregnancy and programs of primary pre-
vention. Itwas to act as an information system that could
respond quickly to specific needs, such as the assessment
ofthe impact ofenvironmental accidents or change or the
suspicion of teratogenic influences from food, drugs, or
other exposures. It was to establish a well-validated and
documented case-series as a basis foretiologic, clinical, or
health service research. Finally, itwas to act as a catalyst
for the setting up of information systems throughout
Europe and ensure that these systems would collect com-
parable, standardized data. It was recognized that as
congenital anomalies are relatively rare and good quality
exhaustive data is expensive and difficult to collect, a
standard European system could potentially allow coun-
tries to pool their data for studies and to exploit their
differences by comparing these data. In 1990, 25 regional
registries in 15 European countries (the twelve countries
of the European Community, Malta, Switzerland, and
Yugoslavia) covered approximately 350,000 births.
The EUROCAT registries were set up according to a
number ofgeneral principles (1). They were to be popula-
tion based, i.e., the population would be defined according
to the residence ofthe motherin order to avoid biases due
tohospitalselection.Theywereto covercongenitalmalfor-
mations in livebirths, stillbirths, and induced abortions
following prenatal diagnosis. They were to use multiple
sources ofinformation and active case-finding, in order to
achieve more complete case ascertainment and more accu-
rate case description than could be possible in systems
dependententirelyonvoluntarynotification ofcases. They
were to extend registration to cases diagnosed after the
neonatalperiodinordertocollectvalidinformation forthe
manylate-manifesting congenitalanomalies,mostnotably
cardiacanomalies. Finally,theywerealltoreportthesame
core information using the same coding system.
The method ofdata collection needed in order to follow
theseprinciples differed inthedifferentregionsofEurope
according to local characteristics and constraints, such as
the types of information systems already in place for
covering the population of interest, the types of medical
servicesavailableineachareaandtheirutilization,andthe
availability of diagnostic information to the registry. The
major issues in setting up the EUROCAT network are
reviewed.
Definition of the Population
A registry can cover a population defined by the resi-
dence ofthe mother (population based) or by the place of
birth (hospital based). What is important is often not the
definition but the result obtained in terms of possible
selection bias and quality ofinformation.
It is assumed that the population ofinterest should be
geographically defined because this can be most readily
related to risk factors and to administrative information
and population statistics. Ifthewomenresidentwithin the
geographic area who choose to deliver outside it (or are
referred to outside hospitals) differaccordingto some risk
factor for congenital anomaly from the resident women
who choose to deliver within the geographic area, then
thereis selectionbias in ahospital-based systembutnotin
a population-based system.
Ahospital-based registry mayunder certain conditions
collect information that is not affected by selection bias. If
all hospitals within a large geographic area are covered,
then it may be only near the boundaries of the area that
significant numbers of nonresident births are included,
and most births to residents will take place within the
area. Even where there are large numbers of immigrant
and emigrant births, ifit can be shown thatthe reason for
immigration oremigrationis notrelated to riskofcongeni-
tal anomaly, then no selection bias should be present. It
should be possible for a hospital-based system to trace in
utero transfers (afterprenatal diagnosis ofmalformation)
entering or leaving the study hospitals for delivery and
take these into consideration.
A hospital-based system can, however, have particular
advantages for the collection ofgood quality information,
since it can be easier to set up close collaboration with a
limited number of clinicians and centers than to trace all
deliveries to residents taking place in widely dispersed
maternity units. This depends on the system ofreferrals
and the cross boundary flow existing in the region. A
hospital-based systemmay also have amore quickly avail-
able setofbirth statistics whenpopulation statistics based
on residence are compiled with a long delay, or when the
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boundaries of the registry area do not coincide with the
boundaries of a suitable administrative district.
A more difficult question is whether the populations
covered canbeconsidered representative ofEurope. Since
EUROCAT has a number ofdifferent objectives, and the
geographic distributions ofthemanyknownandunknown
risk factors may all bevery different, itis impossible for a
sample population to be always representative. Whether
the results can be extrapolated to the entire European
population must bejudged for each individual analysis.
There is aconflictwhen collecting dataforenvironmen-
tal studies, between the need to limit the size of the
registryinorderto collectcomplete andaccurate dataand
the need to obtain coverage across extensive geographical
areas in order to allow geographical comparisons and
ensure that all localized risks will have available local
health outcome information.Where anationalbirth defect
monitoring system is in place, small specialized registries
may be useful in addition to assess, on detection of a
cluster, thepossiblerole ofincomplete ascertainmentorto
provide background epidemiological data needed to inter-
pret the cluster and suggest hypotheses forinvestigation.
Some specialized regional registries can serve to calibrate
the national system, but this is not an easy objective to
achieve, since reporting to the national system and to the
specialized registry will not usually be independent.
At present, large geographic areas in Europe have no
information system covering congenital anomalies, and it
is not clear that putting resources into more complete
geographical coverageratherthanincreasing dataquality
in representative regions would be advisable, keeping in
mind also that environmental studies are only one of the
uses of a congenital anomaly information system.
Definition and Coding of Diagnoses
All participating registries use the common nomencla-
ture and code systemoftheBritish PaediatricAssociation
Classification of Diseases (2), which is a five-digit exten-
sion of the ninth revision of the International Classifica-
tion of Diseases. The McKusick Classification (3) is used
for conditions with Mendelian inheritance. Up to eight
congenital anomalies may be coded for each baby, and a
syndrome, ifrecognized, canbecoded. Cases arereviewed
at the EUROCAT Central Registry by a pediatrician
specializing in pathology and genetics, particularly with
respect to the reporting and recognition ofsyndromes in
babies with multiple anomalies.
There is a limited list ofminor anomalies that are to be
excludedunless occurringincombinationwithothermajor
anomalies. Minor anomalies may not be unimportant in
relation to environmental effects, but there is as yet little
standardization intheirrecognition and they areprobably
more appropriately covered by other types ofinformation
systems than registries.
Coverage of Fetal Deaths
Early fetal deaths or spontaneous abortions are not at
present covered by information systems, although they
maybeofgreatinterestforthe studyofcongenitalmalfor-
mations. Not all such fetal deaths will be known to hospi-
tals or examined for malformation, and no population
statistics for the number of spontaneous abortions occur-
ring in the population are currently known.
Civil registration oflate fetal deaths, stillbirths, is a re-
quirement in all countries of Europe. Whereas formerly
the mostcommonlimitdistinguishingaspontaneous abor-
tionfromastillbirthwas28weeksgestation,thislimithas
been lowered in many countries in response to develop-
ments in neonatal care which have improved the viability
of babies born at earlier gestational ages. The World
Health Organization (WHO) recommended definition is
500 g (4), the average weight of a fetus of 22 weeks.
EUROCATregistries aimto coverallfetaldeathsfrom20
weeks ofgestation. This lowlimit eliminates any artificial
distinctionbetween livebirths and stillbirths oflowgesta-
tional age. This is especially important for malformed
babies considerednottobeviable,such asthosewith anen-
cephaly, since whether they are considered liveborn or
stillbornmaybeinfluencedbymedical customs orsocial or
welfare considerations. Inthecaseofmalformedfetuses, a
gestational age limit is preferable to a birth weight limit
becausemalformedfetuses are often oflowerbirthweight
than normal fetuses ofequal maturity.
Some registries may have difficulties in obtaining infor-
mation on fetal deaths not officially considered stillbirths,
forexample, thoseof20-27weeksofgestation.Thesefetal
deathsoflowgestational agewillalso notbefoundinbirth
statistics,leadingtoaslightdiscrepancybetweennumera-
tor and denominator in calculations of prevalence rates.
However, since malformations are selectively found in
births of low gestation and since it is among malformed
births that the distinction between livebirths and fetal
deaths may be weakest, it is usually better to include
malformedfetaldeaths oflowgestationinthesurveillance
system while remaining aware ofthe problems.
Some stillbirths or late fetal deaths may have obvious
external malformations, while others may be found to be
malformedonlyafterpathologicalexamination. Aregistry
depends ontherebeingahigh autopsyrateandspecialized
fetal pathologists carrying out the autopsy for full infor-
mation about stillbirths, and on the availability ofautopsy
records to the registry.
Registration of Induced Abortions
after Prenatal Diagnosis
Prenataldiagnosisofmalformationisbecomingincreas-
ingly common in many European countries. For some
malformations, this can be followed by termination of
pregnancy or induced abortion. Laws regarding induced
abortion differbetween countries. Itis notlegalin Ireland
or Malta. It is legal in many countries only up to the
gestational age that defines a stillbirth, but exceptions
may be made for malformed fetuses with conditions not
compatible with life, e.g., anencephaly. In France, there is
no upper gestational age limit for induced abortions.
Becausetherateofprenataldiagnosisvariesintimeand
between different geographic populations, it is essential
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for the detection ofchanges and differences in the risk of
manycongenital anomalies thatinduced abortions shouldbe
registered andincludedinthecalculationofprevalencerates.
For the evaluation of the impact of prenatal diagnostic
services, it is also necessary to have these cases regis-
tered. Unfortunately, this information proves to be diffi-
cult to collect in some areas. For some anomalies such as
anencephaly,whichisrelativelyeasytodetectwithroutine
ultrasound, the information problem isworsening as more
and more clinics become involved, instead ofthe centrali-
zation ofthe diagnosis in specialized centers.
Induced abortions canbe aspecialproblemforhospital-
based centers when women resident within the area are
selectivelyreferredtohospitals outsidethe areaforprena-
tal diagnosis and induced abortion or, conversely, when
nonresident women are selectively referred within the
area. It may also be difficult for population-based centers
totracewomenleavingthe areaforprenataldiagnosisand
abortion.
The only induced abortions covered by malformation
registries are those that are carried out for fetal malfor-
mation. The majorityofthese fetuseswould have resulted
in live or stillbirth but for the early diagnosis. It is impor-
tant to realize that induced abortions carried out for rea-
sons other than malformation are notregistered, whether
the fetus is normal ormalformed. Inthese cases, thefetus
is usually not examined for malformation, and even ifit is
examined, it cannotbeincluded inthe numeratorofpreva-
lence rates when the total number of induced abortions
carried out in the population is not included in the
denominator. This denominatorproblem does notarise for
induced abortions carried out because offetal malforma-
tion, since they form at present a negligible proportion of
the total births occurring in the population.
Precision of Diagnostic Information
Once an infant/fetus is known to be malformed, consid-
erable attention must be given to obtaining precise diag-
nostic information. This can come from autopsy records,
laboratory reports and cytogenetic analyses, medical
genetics records, and records of specialized departments
fortreatment ofthe condition, includingradiographs. The
diagnosis may change or become more specific as further
investigation is performed and this requires follow-up of
the child during childhood through its medical records.
Whether follow-up is needed, and what additional type of
information should be sought, depends onthe type ofano-
maly. Diagnostic precision involves two steps: are the
investigationscarriedoutand aretheresultsoftheinvesti-
gations available to the registry?
Registration of Late-Diagnosed Cases
Many congenital anomalies are not yet diagnosed at
birth orintheneonatalperiod,particularlycertaincardiac
anomalies, internal urogenital system anomalies, and cen-
tral nervous system anomalies. Whether anomalies are
diagnosedprenatallyorintheneonatalperiodmaydepend
on screening practices. For comparative purposes and to
estimate the true prevalence rates of these conditions,
sources of information extending beyond the neonatal
period are necessary. Often these are the same sources of
information which will allow follow-up of cases initially
detected neonatally for further details on diagnosis.
Conflict between Quality, Quantity,
and Rapidity
Thereis always aconflictbetween quality, quantity, and
rapidity. The EUROCAT questionnaire is a compromise
between quality and quantity. In general, it is difficult to
collect data about risk factors without specifying the
hypothesisinadvance.Theemphasisisthereforeplacedon
the precision of the diagnostic information, while the
variables concerning risk factors serve mainly as indica-
tors of exposure, markers of cases requiring further
search ofthe medical records or maternal interview.
Therapidityofdatacollectionisinconflictwithboththe
qualityand quantityofdatatobe collected. Itis clearthat
ifourpurposeistodetectanewthalidomide,this shouldbe
done asrapidlyaspossible. Itis notnecessaryforthedata
tobeabsolutelycompleteoraccurate.Tofacilitaterapidity,
transmission to the central EUROCAT registry of incom-
pletecasedata,whichcanbeupdatedwhenfurtherinforma-
tion becomes available, is accepted. However, EUROCAT
has not really been able to resolve this conflict, and up to
nowrapid analyses have been done on a local level but not
on an international level. The international aspect of the
project is more important for facilitating the communica-
tion between registries, so that local observations can be
further investigated in other populations within a short
delay and with known standard methods.
Active Data Collection and Motivation
Reliance on special or voluntary notification from clini-
cians orotherhealthprofessionals is more suited to short,
intensive ad hoc studies or to the registration ofa limited
listofveryrare conditions. Routineregistration ofthe full
range of congenital anomalies requires the active con-
sultation of medical records as well as setting up close
contacts with clinicians. In a long-term registration sys-
tem, one ofthe majorproblems is to maintain agood level
ofmotivation for case finding. Various forms offeedback
may increase motivation, including sending letters with
information on available services to the practicing physi-
cians, organizing seminars, distributing newsletters and
reports with results from the registry, running a
teratogen or genetic information service in parallel to
registration activities, and even supplyingitems ofmutual
benefit such as books,journals, computers, or cameras. It
is important that the data collected are seen to be of
immediate use and oflocal relevance. This favors regional
rather than national registries and the employment of
personnel who can use and evaluate the data as itis being
collected.
Confidentiality
Confidentialityis amajorissueforepidemiologicalregi-
stries. Registries used foranytype ofdisease orprovision
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of health services raise the issue of confidentiality and
protection ofindividual privacy. Strictsafeguards mustbe
established to prevent unauthorized use ofthe records.
In most but not all of the EC countries, special codes
have been enacted for the use of personal data for
research, which applyto health data. In each country, the
EUROCATregistries arebound to respect thelocal regu-
lationregardingmedicaldatabases. Inaddition, European
countries adhere in principle to the general principles
recommended by the Assembly of the European Science
Foundation in a 1980 statement concerning the protection
ofprivacy. Specialregulations applyalsoin somecountries
to the transmitting of computerized information across
international borders.
From the beginnings ofEUROCAT, it was agreed that
the Central Registry will receive no information that
would enable anyone to identify directly or indirectly the
malformed baby or its parents. Names and addresses of
casesandhospitals are never senttotheCentralRegistry.
A local serial number only is transmitted for each baby,
which isused in correspondence with the localregister, or
when there is a need for additional information orfurther
investigation. This rule is applied both for information
reported onprecodedforms oronmagnetictapes (1). Such
amultilevel procedurewith repeated safeguards forconfi-
dentialitypreventanyunauthorized accesstoprivatedata,
and prevent a direct approach to the baby or its parents.
EUROCAT has shown that a multinational use of epi-
demiological data for the purpose of environmental sur-
veillance is feasible while respecting strict rules of
confidentiality and protecting the privacy of the indi-
vidual.
EUROCAT is aConcerted Action supported bythe Commission ofthe
European Communities.
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